Anatoliy Konstantinovich Evseev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Anatoliy Konstantinovich Evseev has a total of 211 co-authors. Here are the top co-authors by number of shared publications:
- Irina V. Goroncharovskaya
N.V. Sklifosovsky Research Institute for Emergency Medicine
33 shared publications - Aslan K. Shabanov
N.V. Sklifosovsky Research Institute for Emergency Medicine
16 shared publications - Sergey S. Petrikov
N.V. Sklifosovsky Research Institute for Emergency Medicine
11 shared publications - Mark M. Goldin
Sklifosovsky Research Institute for Emergency Medicine
8 shared publications M. Sh. Khubutiya
N.V. Sklifosovsky Research Institute for Emergency Medicine
7 shared publicationsV. N. Andreev
Frumkin Institute of Physical Chemistry and Electrochemistry, Russian Academy of Sciences
7 shared publications
Latest Publications
- Open Access
- 7 November 2026
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 71 (3) , 356–365
Influence of hyperbaric oxygenation on electrochemically induced change in the morphology of red blood cells in patients with acute cerebral pathology
Introduction . Assessment of the infl uence of hyperbaric oxygenation on red blood cell properties is a relevant issue, as decreased membrane elasticity leads to deterioration of blood rheological properties and reduced gas exchange effi ciency. One of the new methods for assessing red blood cell deformability is electrochemically induced change in red blood cell morphology. Aim : To study the effect of HBO on electrochemically induced change in the morphology of red blood cells in patients with acute cerebral pathology. Materials and methods . Whole blood samples obtained from 7 patients with acute cerebral pathology, age 57 (47; 65) (Me (IQR)) y, who received a course of hyperbaric oxygenation (HBO) were examined. The procedures were carried out in a Sechrist 2800 chamber (USA) at a mode of 1.4–1.6 AT for no more than 60 minutes. Before and after each HBO session, an assessment of the electrochemically induced change in the morphology of erythrocytes was performed and the erythrocyte deformability index was calculated. Results . It was found that the erythrocyte deformability index estimated via electrochemically induced change in erythrocyte morphology technique increased from 19.96 (5.37; 28.11) % to 21.60 (12.11; 32.30) % (Me (IQR)) (p = 0.07) after the HBO session. Due to the fact that the initial samples predominantly contained erythrocyte shapes echinocytes III and sphero-echinocytes I and II, the morphological changes caused by a shift in the potential of the working electrode to more negative values (up to -0.6 V) were not so pronounced both before and after the HBO session. At the same time, with a shift in the potential to the region of more positive values (up to +1.2 V) in the samples after the HBO session, a tendency towards an increase in the proportion of echinocytes II and III from 24.50 % to 54.64 % (p = 0.084) and a decrease in the proportion of spheroechinocytes I and II from 75.50 % to 30.47 % (p = 0.117) was observed, while the change in the proportion of discocytes and echinocytes I was insignifi cant — 0.68 % and 3.01 % (p = 0.241) before and after the session, respectively. Conclusion . Using a method of electrochemically induced changes in erythrocyte morphology, it was demonstrated that when conducting HBO, there is a tendency to improve the morphofunctional properties of erythrocytes in patients with acute cerebral pathology, resulting in increased erythrocytes deformability. Improved blood rheology infl uences the effi ciency of gas exchange processes, which, in turn, should lead to improved cerebral oxygenation.
- 7 November 2026
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 71 (3) , 356–365
Open AccessInfluence of hyperbaric oxygenation on electrochemically induced change in the morphology of red blood cells in patients with acute cerebral pathology
Introduction . Assessment of the infl uence of hyperbaric oxygenation on red blood cell properties is a relevant issue, as decreased membrane elasticity leads to deterioration of blood rheological properties and reduced gas exchange effi ciency. One of the new methods for assessing red blood cell deformability is electrochemically induced change in red blood cell morphology. Aim : To study the effect of HBO on electrochemically induced change in the morphology of red blood cells in patients with acute cerebral pathology. Materials and methods . Whole blood samples obtained from 7 patients with acute cerebral pathology, age 57 (47; 65) (Me (IQR)) y, who received a course of hyperbaric oxygenation (HBO) were examined. The procedures were carried out in a Sechrist 2800 chamber (USA) at a mode of 1.4–1.6 AT for no more than 60 minutes. Before and after each HBO session, an assessment of the electrochemically induced change in the morphology of erythrocytes was performed and the erythrocyte deformability index was calculated. Results . It was found that the erythrocyte deformability index estimated via electrochemically induced change in erythrocyte morphology technique increased from 19.96 (5.37; 28.11) % to 21.60 (12.11; 32.30) % (Me (IQR)) (p = 0.07) after the HBO session. Due to the fact that the initial samples predominantly contained erythrocyte shapes echinocytes III and sphero-echinocytes I and II, the morphological changes caused by a shift in the potential of the working electrode to more negative values (up to -0.6 V) were not so pronounced both before and after the HBO session. At the same time, with a shift in the potential to the region of more positive values (up to +1.2 V) in the samples after the HBO session, a tendency towards an increase in the proportion of echinocytes II and III from 24.50 % to 54.64 % (p = 0.084) and a decrease in the proportion of spheroechinocytes I and II from 75.50 % to 30.47 % (p = 0.117) was observed, while the change in the proportion of discocytes and echinocytes I was insignifi cant — 0.68 % and 3.01 % (p = 0.241) before and after the session, respectively. Conclusion . Using a method of electrochemically induced changes in erythrocyte morphology, it was demonstrated that when conducting HBO, there is a tendency to improve the morphofunctional properties of erythrocytes in patients with acute cerebral pathology, resulting in increased erythrocytes deformability. Improved blood rheology infl uences the effi ciency of gas exchange processes, which, in turn, should lead to improved cerebral oxygenation.
- Open Access
- 11 November 2024
- Published by Scientific Center for Biomedical Technologies of the Federal Medical-Biological Agency in Journal Biomed
- Vol. 20 (3) , 114-120
In vivo Study of the Anti/Prooxidant Activity of a Metal-Organic Coordination Polymer Modified with Iron Oxides and Ascorbic Acid
Experiments on 39 male Wistar rats were performed. A metal-organic coordination polymer modified with iron oxide and ascorbic acid (composite) was administered intravenously to healthy rats at doses of 25 and 50 mg/kg. The anti/prooxidant activity of the composite was assessed 3 and 24 hours after administration. The composite in both doses was shown to have no significant effect on the homeostasis of prooxidants/antioxidants in the blood serum in healthy animals. In high doses, the composite enhances apoptosis of lymphocytes, which indicates its possible use as a catalyst for free radical processes for further use in biomedicine.
- 11 November 2024
- Published by Scientific Center for Biomedical Technologies of the Federal Medical-Biological Agency in Journal Biomed
- Vol. 20 (3) , 114-120
Open AccessIn vivo Study of the Anti/Prooxidant Activity of a Metal-Organic Coordination Polymer Modified with Iron Oxides and Ascorbic Acid
Experiments on 39 male Wistar rats were performed. A metal-organic coordination polymer modified with iron oxide and ascorbic acid (composite) was administered intravenously to healthy rats at doses of 25 and 50 mg/kg. The anti/prooxidant activity of the composite was assessed 3 and 24 hours after administration. The composite in both doses was shown to have no significant effect on the homeostasis of prooxidants/antioxidants in the blood serum in healthy animals. In high doses, the composite enhances apoptosis of lymphocytes, which indicates its possible use as a catalyst for free radical processes for further use in biomedicine.
- 2 November 2024
- Published by Alfmed LLC in Medical alphabet
- No. 20,p. 59-64
Comparing quality parameters of apheresis and pooled platelet concentrates
Introduction. Harvesting of pooled platelet concentrates (PC) significantly expands the volume of transfusion support and could be used to create strategic platelet reserve.The aim of work. To compare the quality of pooled and apheresis platelet concentrates.Materials and methods. We studied platelet fractions (PF), isolated from the whole blood of cadre donors with Reveos system, platelet concentrates, obtained by pooling PF (Pooled PC), and platelet concentrates harvested by automatic apheresis. In all cases 2 days passed from the moment of blood donation to the platelet examination. In PC samples we studied cellular composition, morphofunctional parameters of platelets, pH and electrochemical parameters, hypotonic shock response.Results. The morphofunctional platelet rate in PF was significantly reduced, comparing to the normal levels. At the same time, the morphofunctional parameters of platelets did not significantly differ in PF and pooled PC. The pH values, the total content of platelets and leukocytes in the pooled PC corresponded to the requirements of The rules for procurement, storage, transportation and clinical use of donated blood and its components (2019). The total platelet count, the level of annexin-positive platelets, did not significantly differ in apheresis PC and pooled PC, hypotonic shock response was correct in apheresis PC and pooled PC. On the other hand, the level of platelets with granules in pooled PC was 1,8 times lower than in apheresis PC, other morphofunctional parameters of platelets in pooled PC were also reduced. Pooled PC were characterized by more positive level of open circuit potential and lower antioxidant capacity compared with apheresis PC on the same storage time.Conclusions. Platelet pooling with Reveos system is acceptable for obtaining PC doses that comply with Technical Regulations. Nevertheless, methods of pooled PC harvesting need further optimization.
- 2 November 2024
- Published by Alfmed LLC in Medical alphabet
- No. 20,p. 59-64
Comparing quality parameters of apheresis and pooled platelet concentrates
Introduction. Harvesting of pooled platelet concentrates (PC) significantly expands the volume of transfusion support and could be used to create strategic platelet reserve.The aim of work. To compare the quality of pooled and apheresis platelet concentrates.Materials and methods. We studied platelet fractions (PF), isolated from the whole blood of cadre donors with Reveos system, platelet concentrates, obtained by pooling PF (Pooled PC), and platelet concentrates harvested by automatic apheresis. In all cases 2 days passed from the moment of blood donation to the platelet examination. In PC samples we studied cellular composition, morphofunctional parameters of platelets, pH and electrochemical parameters, hypotonic shock response.Results. The morphofunctional platelet rate in PF was significantly reduced, comparing to the normal levels. At the same time, the morphofunctional parameters of platelets did not significantly differ in PF and pooled PC. The pH values, the total content of platelets and leukocytes in the pooled PC corresponded to the requirements of The rules for procurement, storage, transportation and clinical use of donated blood and its components (2019). The total platelet count, the level of annexin-positive platelets, did not significantly differ in apheresis PC and pooled PC, hypotonic shock response was correct in apheresis PC and pooled PC. On the other hand, the level of platelets with granules in pooled PC was 1,8 times lower than in apheresis PC, other morphofunctional parameters of platelets in pooled PC were also reduced. Pooled PC were characterized by more positive level of open circuit potential and lower antioxidant capacity compared with apheresis PC on the same storage time.Conclusions. Platelet pooling with Reveos system is acceptable for obtaining PC doses that comply with Technical Regulations. Nevertheless, methods of pooled PC harvesting need further optimization.
- Open Access
- 6 September 2024
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 13 (2) , 312-321
Safety of Extended Sedation with Sevoflurane in Patients with Severe Traumatic Brain Injury
RELEVANCE. In conditions of increased sensitivity of damaged brain tissue to disruption of homeostasis, it is important to achieve stabilization of the vital functions of the body as soon as possible. Given the excess afferent impulse, adequate sedation and analgesia are an integral component of intensive care for patients with traumatic brain injury. The use of halogenated anesthetics is associated with a lower risk of complications associated with long-term sedation with intravenous drugs. In the example of two patients with severe traumatic brain injury, the effectiveness and safety of sevoflurane for prolonged inhalation sedation was noted. This study was approved at a meeting of the Local Ethics Committee of the Federal Scientific and Clinical Center for Resuscitation and Rehabilitation, an extract from protocol No. 5/21/1 dated December 23, 2021, as well as at a meeting of the LEC of the N. V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department, meeting No. 1-2022 dated January 11, 2022. AIM OF STUDY. To demonstrate the safety of inhalation sedation in patients with traumatic brain injury using clinical observations as an example. MATERIAL AND METHODS. An analysis of two clinical observations of patients with severe traumatic brain injury was carried out. The effectiveness and safety of prolonged inhalation sedation was assessed by indicators: intracranial pressure, dynamics of mean arterial pressure and blood saturation in the jugular vein bulb, as well as the total duration of artificial ventilation and stay in the intensive care unit. Clinical observation No. 1. Patient B., 41 years old, was admitted with cerebral insufficiency (GCS 8) with damage to the soft tissues of the head. As a result of the examination, the patient wasdiagnosed with “Closed craniocerebral injury.” Fracture of the bones of the vault and base of the skull. Severe brain contusion. Traumatic subarachnoid hemorrhage, acute subdural hematoma in the left frontotemporal region 3 cm3”. Considering the size of the trauma (65 cm3) and the life-threatening dislocation syndrome, the patient underwent surgical intervention: “Decompressive craniotomy, removal of contusion areas. Installation of a ventricular intracranial pressure sensor.” The early course of the postoperative period was complicated by the development of infectious complications, which led to the need for prolonged sedation in the intensive care unit. On the 3rd day, a lower tracheostomy was performed. The total time of sedation was 3 days, and the duration of artificial ventilation was 10 days. On the 21st day, the patient was decannulated and transferred to a specialized department. Clinical observation No. 2. Patient K, 42 years old, was admitted to the hospital with a depressed level of consciousness (GCS 6). Based on the results of the examination, a diagnosis was made: “Penetrating traumatic brain injury with severe brain contusion, a focus of crush contusion in the right temporal lobe, acute subdural hematoma of the right frontal-temporo-parietal region 100 cm3 and a fracture of the bones of the vault and base of the skull, facial skeleton, micropneumocephaly”. Considering the size and location of the hematoma, the patient underwent surgery including decompressive craniotomy, removal of an acute subdural hematoma, and a Spiegelberg intracranial pressure sensor was installed. In the early postoperative period, severe hemodynamic instability associated with vascular insufficiency of central origin was noted. The use of inhalational sedation sevoflurane did not lead to the development of intracranial hypertension and escalation of vasopressor therapy. The total time of use of sevoflurane was 36 hours. Spontaneous breathing was restored by the 18th day. The patient’s stay in the ICU was 31 bed days. CONCLUSION. Based on the data obtained, we may conclude that the use of inhalation sedation in this category of patients is safe, as well as the absence of a significant effect of sevoflurane on the level of intracranial pressure and central hemodynamic parameters. However, secondary complications that developed in patients do not allow us to draw an unambiguous conclusion about the effect of this method of sedation on the duration of artificial ventilation and stay in the intensive care unit. Only the accumulation of a sufficient volume of clinical material will reveal all the advantages and disadvantages of this method.
- 6 September 2024
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 13 (2) , 312-321
Open AccessSafety of Extended Sedation with Sevoflurane in Patients with Severe Traumatic Brain Injury
RELEVANCE. In conditions of increased sensitivity of damaged brain tissue to disruption of homeostasis, it is important to achieve stabilization of the vital functions of the body as soon as possible. Given the excess afferent impulse, adequate sedation and analgesia are an integral component of intensive care for patients with traumatic brain injury. The use of halogenated anesthetics is associated with a lower risk of complications associated with long-term sedation with intravenous drugs. In the example of two patients with severe traumatic brain injury, the effectiveness and safety of sevoflurane for prolonged inhalation sedation was noted. This study was approved at a meeting of the Local Ethics Committee of the Federal Scientific and Clinical Center for Resuscitation and Rehabilitation, an extract from protocol No. 5/21/1 dated December 23, 2021, as well as at a meeting of the LEC of the N. V. Sklifosovsky Research Institute for Emergency Medicine of the Moscow Health Department, meeting No. 1-2022 dated January 11, 2022. AIM OF STUDY. To demonstrate the safety of inhalation sedation in patients with traumatic brain injury using clinical observations as an example. MATERIAL AND METHODS. An analysis of two clinical observations of patients with severe traumatic brain injury was carried out. The effectiveness and safety of prolonged inhalation sedation was assessed by indicators: intracranial pressure, dynamics of mean arterial pressure and blood saturation in the jugular vein bulb, as well as the total duration of artificial ventilation and stay in the intensive care unit. Clinical observation No. 1. Patient B., 41 years old, was admitted with cerebral insufficiency (GCS 8) with damage to the soft tissues of the head. As a result of the examination, the patient wasdiagnosed with “Closed craniocerebral injury.” Fracture of the bones of the vault and base of the skull. Severe brain contusion. Traumatic subarachnoid hemorrhage, acute subdural hematoma in the left frontotemporal region 3 cm3”. Considering the size of the trauma (65 cm3) and the life-threatening dislocation syndrome, the patient underwent surgical intervention: “Decompressive craniotomy, removal of contusion areas. Installation of a ventricular intracranial pressure sensor.” The early course of the postoperative period was complicated by the development of infectious complications, which led to the need for prolonged sedation in the intensive care unit. On the 3rd day, a lower tracheostomy was performed. The total time of sedation was 3 days, and the duration of artificial ventilation was 10 days. On the 21st day, the patient was decannulated and transferred to a specialized department. Clinical observation No. 2. Patient K, 42 years old, was admitted to the hospital with a depressed level of consciousness (GCS 6). Based on the results of the examination, a diagnosis was made: “Penetrating traumatic brain injury with severe brain contusion, a focus of crush contusion in the right temporal lobe, acute subdural hematoma of the right frontal-temporo-parietal region 100 cm3 and a fracture of the bones of the vault and base of the skull, facial skeleton, micropneumocephaly”. Considering the size and location of the hematoma, the patient underwent surgery including decompressive craniotomy, removal of an acute subdural hematoma, and a Spiegelberg intracranial pressure sensor was installed. In the early postoperative period, severe hemodynamic instability associated with vascular insufficiency of central origin was noted. The use of inhalational sedation sevoflurane did not lead to the development of intracranial hypertension and escalation of vasopressor therapy. The total time of use of sevoflurane was 36 hours. Spontaneous breathing was restored by the 18th day. The patient’s stay in the ICU was 31 bed days. CONCLUSION. Based on the data obtained, we may conclude that the use of inhalation sedation in this category of patients is safe, as well as the absence of a significant effect of sevoflurane on the level of intracranial pressure and central hemodynamic parameters. However, secondary complications that developed in patients do not allow us to draw an unambiguous conclusion about the effect of this method of sedation on the duration of artificial ventilation and stay in the intensive care unit. Only the accumulation of a sufficient volume of clinical material will reveal all the advantages and disadvantages of this method.
- Open Access
- 1 January 2024
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 89 (4) , 539-549
Electrochemical analysis of antioxidant status of biological media in different sampling and storage conditions
The use of an electrochemical approach for assessment of the oxidative stress severity is a promising direction for point-of-care testing development, which is especially important for critically ill patients. The aim of this study was to determine the influence of different types of blood collection tubes (with clot activator and separating gel, lithium heparin, sodium citrate and K2EDTA) and storage conditions (at +25°C, +4°C and -23°C up to 5 days) on the electrochemical analysis of the antioxidant status of blood plasma, assessed by measuring the open circuit potential of platinum electrode (OCP, mV) and antioxidant capacity via cyclic voltammetry method (q, μC). It was obtained that blood collection tubes with lithium heparin and clot activator are the most suitable for the electrochemical analysis of antioxidant status of blood plasma, since they do not affect the results of measurements. Furthermore, data obtained during storage blood plasma samples in different temperature conditions indicate that it is preferable to perform electrochemical analysis in fresh samples.
- 1 January 2024
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- Vol. 89 (4) , 539-549
Open AccessElectrochemical analysis of antioxidant status of biological media in different sampling and storage conditions
The use of an electrochemical approach for assessment of the oxidative stress severity is a promising direction for point-of-care testing development, which is especially important for critically ill patients. The aim of this study was to determine the influence of different types of blood collection tubes (with clot activator and separating gel, lithium heparin, sodium citrate and K2EDTA) and storage conditions (at +25°C, +4°C and -23°C up to 5 days) on the electrochemical analysis of the antioxidant status of blood plasma, assessed by measuring the open circuit potential of platinum electrode (OCP, mV) and antioxidant capacity via cyclic voltammetry method (q, μC). It was obtained that blood collection tubes with lithium heparin and clot activator are the most suitable for the electrochemical analysis of antioxidant status of blood plasma, since they do not affect the results of measurements. Furthermore, data obtained during storage blood plasma samples in different temperature conditions indicate that it is preferable to perform electrochemical analysis in fresh samples.
- Open Access
- 30 October 2023
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 185-196
The effect of a tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine diacetate (Dalargin) on oxidative stress in patients with severe combined trauma: a prospective clinical study
INTRODUCTION: Severe combined trauma remains the leading cause of mortality and disability of the workable population. Under damaging factor influence, a whole cascade of pathological processes is triggered, leading to development of multiple organ failure. OBJECTIVE: Exploration of the effects synthetic analogue of tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine diacetate (Dalargin) on the dynamics of oxidative stress markers in patients with severe polytrauma and the development of organ dysfunction. MATERIALS AND METHODS: 104 patients with severe combined trauma were included in study. There were 38 patients in the Dalargin group and 66 patients in the control group. Patients from main group received Dalargin in the form of a constant infusion through a syringe dispenser at the dose of 10 mcg/kg/hour at first 12 hours of hospitalization and 5 mcg/kg/hour up to 72 hours from the moment of admission. The control group received standard treatment. Indicators of oxidative stress were evaluated at the time of admission (0 days), 1, 3, 5, 7, 10 and 14 days from the therapy onset. RESULTS: In the main group, there was a significant decrease in oxidative stress markers such as malondialdehyde from the first day of treatment (p < 0.05), normalization of stable nitric oxide metabolites at day 10, and a decrease in total antioxidant activity below normal throughout the observation period. Mortality was comparable in both groups (p > 0.05), but the length of hospital stay was lower in surviving patients in the Dalargin group (p < 0.05). The development of organ dysfunction (acute respiratory distress syndrome, acute kidney injury) was less frequent in the Dalargine group (p < 0.05), but infectious complications (pneumonia, meningitis, wound suppuration) were comparable. CONCLUSIONS: Dalargin leads to a decrease of oxidative stress markers and normalization of endothelial function indicators, which contributes to a decrease of organ dysfunction frequency.
- 30 October 2023
- Published by Practical Medicine Publishing House in Annals of Critical Care
- No. 4,p. 185-196
Open AccessThe effect of a tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine diacetate (Dalargin) on oxidative stress in patients with severe combined trauma: a prospective clinical study
INTRODUCTION: Severe combined trauma remains the leading cause of mortality and disability of the workable population. Under damaging factor influence, a whole cascade of pathological processes is triggered, leading to development of multiple organ failure. OBJECTIVE: Exploration of the effects synthetic analogue of tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine diacetate (Dalargin) on the dynamics of oxidative stress markers in patients with severe polytrauma and the development of organ dysfunction. MATERIALS AND METHODS: 104 patients with severe combined trauma were included in study. There were 38 patients in the Dalargin group and 66 patients in the control group. Patients from main group received Dalargin in the form of a constant infusion through a syringe dispenser at the dose of 10 mcg/kg/hour at first 12 hours of hospitalization and 5 mcg/kg/hour up to 72 hours from the moment of admission. The control group received standard treatment. Indicators of oxidative stress were evaluated at the time of admission (0 days), 1, 3, 5, 7, 10 and 14 days from the therapy onset. RESULTS: In the main group, there was a significant decrease in oxidative stress markers such as malondialdehyde from the first day of treatment (p < 0.05), normalization of stable nitric oxide metabolites at day 10, and a decrease in total antioxidant activity below normal throughout the observation period. Mortality was comparable in both groups (p > 0.05), but the length of hospital stay was lower in surviving patients in the Dalargin group (p < 0.05). The development of organ dysfunction (acute respiratory distress syndrome, acute kidney injury) was less frequent in the Dalargine group (p < 0.05), but infectious complications (pneumonia, meningitis, wound suppuration) were comparable. CONCLUSIONS: Dalargin leads to a decrease of oxidative stress markers and normalization of endothelial function indicators, which contributes to a decrease of organ dysfunction frequency.
- Open Access
- 29 July 2023
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 12 (2) , 250-258
Effects of Xenon on Neuroinflammatory Markers: a Prospective Pilot Study
The leading role of neuroinflammation as the culprit of a long-term impairment of consciousness in patients after injuries to the central nervous system forces us to look for new effective strategies for resolving this pathological process. Xenon reducing the intensity of the inflammatory response due to the impact on several links is potentially able to have a beneficial effect on this category of patients. Using laboratory equipment, we evaluated the effect of half-hour daily inhalations of a 30% air mixture with 30% xenon for 7 days on the level of markers of neuronal damage and regeneration of nervous tissue.AIM To study the effect of inhalation of an air-xenon mixture on the dynamics of markers of neuroinflammation and restoration of nervous tissue in patients after traumatic brain injury (TBI).MATERIAL AND METHODS We conducted a prospective randomized clinical trial evaluating the effect of inhaled xenon for sedation on the level of consciousness and spasticity in patients with prolonged post-coma impairment of consciousness. Patients were randomized into 2 equal groups. In Group I (Comparison, n=15) in addition to the standard treatment for TBI, each patient included in the study underwent 7 sessions of inhalation of an air mixture with an oxygen content of at least 30 vol.% for 30 minutes. In Group II (Xenon, n=15) in addition to the standard treatment, each patient included in the study underwent a half-hour inhalation with an air-xenon gas mixture (with a xenon content of 30 vol.% and oxygen — 30 vol.%) for 7 days, 1 time per day. The levels of interleukin-6, α-1 acid glycoprotein (AGP), S100 b protein and brain-derived neurotrophic factor were assessed before the first treatment and then once a day for 6 days.RESULTS The final evaluation included 12 patients from the Comparison Group and 12 patients from the Xenon Group. The greatest difference in the concentration of interleukin-6 between the Comparison and Xenon Groups was noted on the 5th day - 12.31 (10.21; 15.43) pg/ml vs. 7.93 (3.61; 9.27) pg/ml, respectively; however, the findings only tended to be statistically significant (p=0.07). When assessing the AGP level, the maximum difference was noted on the 4th day. In the Comparison Group, the AGP level was 0.81 (0.74; 0.92) pg/ml versus 0.614 (0.4; 0.79) pg/ml in the Xenon Group. And again, the data showed only a trend towards statistical significance (p=0.09). The highest level of brain-derived neurotrophic factor in the Xenon Group was observed on the 3th day — 0.1271 (0.046; 0.2695) pg/ml, which was statistically significantly higher than the one in the Comparison Group — 0.062 (0.036; 0.121) pg/ml (p=0.04). The concentration of S100 b protein during the entire observation period in both groups did not exceed 0.005 pg/ml.CONCLUSION Xenon inhalation according to the method proposed by the authors had a beneficial effect on the processes of neural tissue regeneration, however, with regard to neuroinflammation, its effects were not so pronounced.
- 29 July 2023
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 12 (2) , 250-258
Open AccessEffects of Xenon on Neuroinflammatory Markers: a Prospective Pilot Study
The leading role of neuroinflammation as the culprit of a long-term impairment of consciousness in patients after injuries to the central nervous system forces us to look for new effective strategies for resolving this pathological process. Xenon reducing the intensity of the inflammatory response due to the impact on several links is potentially able to have a beneficial effect on this category of patients. Using laboratory equipment, we evaluated the effect of half-hour daily inhalations of a 30% air mixture with 30% xenon for 7 days on the level of markers of neuronal damage and regeneration of nervous tissue.AIM To study the effect of inhalation of an air-xenon mixture on the dynamics of markers of neuroinflammation and restoration of nervous tissue in patients after traumatic brain injury (TBI).MATERIAL AND METHODS We conducted a prospective randomized clinical trial evaluating the effect of inhaled xenon for sedation on the level of consciousness and spasticity in patients with prolonged post-coma impairment of consciousness. Patients were randomized into 2 equal groups. In Group I (Comparison, n=15) in addition to the standard treatment for TBI, each patient included in the study underwent 7 sessions of inhalation of an air mixture with an oxygen content of at least 30 vol.% for 30 minutes. In Group II (Xenon, n=15) in addition to the standard treatment, each patient included in the study underwent a half-hour inhalation with an air-xenon gas mixture (with a xenon content of 30 vol.% and oxygen — 30 vol.%) for 7 days, 1 time per day. The levels of interleukin-6, α-1 acid glycoprotein (AGP), S100 b protein and brain-derived neurotrophic factor were assessed before the first treatment and then once a day for 6 days.RESULTS The final evaluation included 12 patients from the Comparison Group and 12 patients from the Xenon Group. The greatest difference in the concentration of interleukin-6 between the Comparison and Xenon Groups was noted on the 5th day - 12.31 (10.21; 15.43) pg/ml vs. 7.93 (3.61; 9.27) pg/ml, respectively; however, the findings only tended to be statistically significant (p=0.07). When assessing the AGP level, the maximum difference was noted on the 4th day. In the Comparison Group, the AGP level was 0.81 (0.74; 0.92) pg/ml versus 0.614 (0.4; 0.79) pg/ml in the Xenon Group. And again, the data showed only a trend towards statistical significance (p=0.09). The highest level of brain-derived neurotrophic factor in the Xenon Group was observed on the 3th day — 0.1271 (0.046; 0.2695) pg/ml, which was statistically significantly higher than the one in the Comparison Group — 0.062 (0.036; 0.121) pg/ml (p=0.04). The concentration of S100 b protein during the entire observation period in both groups did not exceed 0.005 pg/ml.CONCLUSION Xenon inhalation according to the method proposed by the authors had a beneficial effect on the processes of neural tissue regeneration, however, with regard to neuroinflammation, its effects were not so pronounced.
- Open Access
- 11 April 2023
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 14 (1) , 6-11
Electrochemical measurements of the levels of nitric oxide metabolites in the blood serum
Background: Sepsis is a serious clinical condition caused by a dysregulated immune response to infection resulting in multiple organ failure. In the pathogenesis of sepsis, especially that of septic shock, great importance is given to the endothelial marker of vascular regulation, nitric oxide (NO). In septic shock, dysregulation of the vascular tone plays a key role in the development of hypotension. Therefore, the control of the level of nitric oxide and its stable metabolites in critically ill patients is a very important task. Aim: the aim of this study was to evaluate the potential of the electrochemical nitrite detection in the patients blood serum. Methods: The levels of nitric oxide stable metabolites in the blood serum of healthy individuals (n=20) and septic patients (n=25) were studied by the electrochemical method using a composite electrode and by the spectrophotometric method using the Griess reagent. Results: The data in the groups of healthy people and patients with sepsis differ significantly (p 0.00001) both when measured using electrochemical and spectrophotometric methods. The median value of the current response in healthy people was 0.41 A (0.33; 0.55), and the total content of nitric oxide metabolites (NOx) was 26.8 mol/L (20.8; 31.0), while in patients with sepsis, these values were 0.79 A (0.61; 1.28) and 38.89 mol/L (29.64; 57.45), respectively. A negative correlation was found between the data obtained for practically healthy persons (r=-0.696, p=0.0007). Conclusion: The obtained results allow us to conclude that the nitrite measurement in the blood serum by amperometry using a composite electrode is promising as a diagnostic technique.
- 11 April 2023
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 14 (1) , 6-11
Open AccessElectrochemical measurements of the levels of nitric oxide metabolites in the blood serum
Background: Sepsis is a serious clinical condition caused by a dysregulated immune response to infection resulting in multiple organ failure. In the pathogenesis of sepsis, especially that of septic shock, great importance is given to the endothelial marker of vascular regulation, nitric oxide (NO). In septic shock, dysregulation of the vascular tone plays a key role in the development of hypotension. Therefore, the control of the level of nitric oxide and its stable metabolites in critically ill patients is a very important task. Aim: the aim of this study was to evaluate the potential of the electrochemical nitrite detection in the patients blood serum. Methods: The levels of nitric oxide stable metabolites in the blood serum of healthy individuals (n=20) and septic patients (n=25) were studied by the electrochemical method using a composite electrode and by the spectrophotometric method using the Griess reagent. Results: The data in the groups of healthy people and patients with sepsis differ significantly (p 0.00001) both when measured using electrochemical and spectrophotometric methods. The median value of the current response in healthy people was 0.41 A (0.33; 0.55), and the total content of nitric oxide metabolites (NOx) was 26.8 mol/L (20.8; 31.0), while in patients with sepsis, these values were 0.79 A (0.61; 1.28) and 38.89 mol/L (29.64; 57.45), respectively. A negative correlation was found between the data obtained for practically healthy persons (r=-0.696, p=0.0007). Conclusion: The obtained results allow us to conclude that the nitrite measurement in the blood serum by amperometry using a composite electrode is promising as a diagnostic technique.
- Open Access
- 2 February 2023
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (4) , 592-599
A New Strategy for the Treatment of Patients With Prolonged Impairment of Consciousness Using Xenon. Prospective Pilot Study
In addition to high mortality, craniocerebral injuries have another danger, a long rehabilitation period and a high percentage of disability with the development of cognitive impairment. This is primarily associated with the processes of neuroinflammation, which development, according to recent data, leads to a long-term impairment of consciousness. The anti-inflammatory effects of xenon inhalation anesthetic, which have been repeatedly shown in previous studies, have the potential to beneficially affect the level of consciousness in these patients by targeting key links of neuroinflammation.AIM OF STUDY To evaluate the effect of oxygen-xenon mixture inhalation on the level of consciousness recovery and the severity of spastic activity in patients after traumatic brain injury.MATERIAL AND METHODS A prospective randomized clinical trial of the effect of inhaled xenon sedation on the level of consciousness and spastic activity in patients with post-coma long-term impairment of consciousness was conducted. Patients were randomized into two equal groups. In group I (comparisons, n=15) (in addition to the standard treatment after a traumatic brain injury), each patient included in the study underwent 7 sessions of inhalation of an air-oxygen mixture with an oxygen content of at least 30 vol% for 30 minutes. In group II (study, n=15) (in addition to standard treatment), each patient included in the study inhaled an oxygen-xenon gas mixture (xenon content 30 vol%) for 7 days 1 time per day. Before and after the course of treatment (on the 7th day), patients were assessed using the CRS-R scale and the modified Ashworth scale.RESULTS The final evaluation included 12 patients from the comparison group and 12 patients from the study group. Three patients were excluded from each group as a result of critical incidents not related to the type of the therapy. In the comparison group on the 7th day, the level of consciousness was score 9 [7; 11] and did not differ statistically significantly from the baseline (p>0.05), which was score 8 [6; 10]. Spastic activity also did not change statistically significantly. In group II, the initial level of consciousness was 9 [7; 10], and on the 7th day — score 15 [12; 17], which was statistically significantly higher both in relation to the level of consciousness by the 1st day (p=0.021) within the group, and in relation to it on the 7th day in group I (p=0.038). When comparing spastic activity on the 1st and 7th days, we did not obtain a statistically significant difference in any of the groups.CONCLUSION Our method of xenon inhalation made it possible to have a beneficial effect on the level of consciousness of patients after traumatic brain injury, but this did not affect the final level of spastic activity in any way.
- 2 February 2023
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (4) , 592-599
Open AccessA New Strategy for the Treatment of Patients With Prolonged Impairment of Consciousness Using Xenon. Prospective Pilot Study
In addition to high mortality, craniocerebral injuries have another danger, a long rehabilitation period and a high percentage of disability with the development of cognitive impairment. This is primarily associated with the processes of neuroinflammation, which development, according to recent data, leads to a long-term impairment of consciousness. The anti-inflammatory effects of xenon inhalation anesthetic, which have been repeatedly shown in previous studies, have the potential to beneficially affect the level of consciousness in these patients by targeting key links of neuroinflammation.AIM OF STUDY To evaluate the effect of oxygen-xenon mixture inhalation on the level of consciousness recovery and the severity of spastic activity in patients after traumatic brain injury.MATERIAL AND METHODS A prospective randomized clinical trial of the effect of inhaled xenon sedation on the level of consciousness and spastic activity in patients with post-coma long-term impairment of consciousness was conducted. Patients were randomized into two equal groups. In group I (comparisons, n=15) (in addition to the standard treatment after a traumatic brain injury), each patient included in the study underwent 7 sessions of inhalation of an air-oxygen mixture with an oxygen content of at least 30 vol% for 30 minutes. In group II (study, n=15) (in addition to standard treatment), each patient included in the study inhaled an oxygen-xenon gas mixture (xenon content 30 vol%) for 7 days 1 time per day. Before and after the course of treatment (on the 7th day), patients were assessed using the CRS-R scale and the modified Ashworth scale.RESULTS The final evaluation included 12 patients from the comparison group and 12 patients from the study group. Three patients were excluded from each group as a result of critical incidents not related to the type of the therapy. In the comparison group on the 7th day, the level of consciousness was score 9 [7; 11] and did not differ statistically significantly from the baseline (p>0.05), which was score 8 [6; 10]. Spastic activity also did not change statistically significantly. In group II, the initial level of consciousness was 9 [7; 10], and on the 7th day — score 15 [12; 17], which was statistically significantly higher both in relation to the level of consciousness by the 1st day (p=0.021) within the group, and in relation to it on the 7th day in group I (p=0.038). When comparing spastic activity on the 1st and 7th days, we did not obtain a statistically significant difference in any of the groups.CONCLUSION Our method of xenon inhalation made it possible to have a beneficial effect on the level of consciousness of patients after traumatic brain injury, but this did not affect the final level of spastic activity in any way.
- Open Access
- 1 February 2023
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (4) , 561-572
Neuroprotective Effects of Inhaled Xenon for Sedation Compared With Propofol Intravenous Sedation in Severe Ischemic Stroke
ABSTRACTS Ischemic stroke occupies a leading position among the causes of mortality and disability. Long-lasting motor and cognitive impairments, a decrease in the level of consciousness over time aggravate the course of the disease, leading to immobilization syndrome and comorbidity load, which contributes to the development of life-threatening conditions in this category of patients. In this regard, the search for new neuroprotective strategies used at an early stage and capable of minimizing the severe consequences of stroke for the patient in particular and society as a whole seems extremely relevant. The paper presents the effect of inhaled xenon for sedation in patients with severe ischemic stroke on the level of consciousness and severity of neurological disorders, and also shows its effect on S100B protein, a marker for blood brain barrier damage.AIM OF STUDY To evaluate the effect of inhaled xenon for sedation in comparison with propofol intravenous sedation on the dynamics of the level of consciousness, the severity of neurological dysfunction and changes in the concentration of astroglial-derived S100B protein in severe ischemic stroke.MATERIAL AND METHODS The research was conducted on two groups of patients comparable in age, gender, comorbid background, as well as the severity of the underlying disease. In both groups, the condition of patients required the start of mechanical ventilation immediately after admission to the intensive care unit. Group I (control, n=12). After intubation and the start of ventilation, patients were sedated with propofol at a dose of 1-2 mg/ kg / hour for 24–72 hours. Group II (xenon, n=12). After intubation and the start of ventilation, patients underwent xenon inhalation at a concentration of 40 vol. % for the first 6 hours. If it was necessary to continue sedation after the end of xenon inhalation, propofol was used in doses similar to Group I. Neurological status was assessed on days 1, 3 and 8 using the Glasgow Coma Scale (GCS), the Full Outline of UnResponsivness (FOUR) score and the National Institutes of Health Stroke Scale (NIHSS). The critical analysis of the value of S100B as a marker of brain damage was carried out before the start of sedation, on the 3rd and 8th days.RESULTS Xenon inhalation (40 vol. %) in comparison with propofol intravenous sedation significantly increases the level of consciousness in patients with severe ischemic stroke (p=0,026), reduces neurological disorders assessed using NIHSS (p=0,007) on day 7, and also reduces serum S100B levels on day 3 (pCONCLUSION Our open randomized clinical trial of xenon inhalation versus propofol intravenous sedation revealed the neuroprotective properties of xenon anesthesia in patients with severe ischemic stroke. Based on the obtained clinical and laboratory data, it can be concluded about the effective implementation of the neuroprotective effects of xenon in the administration scheme used in the research.
- 1 February 2023
- Published by The Scientific and Practical Society of Emergency Medicine Physicians in Russian Sklifosovsky Journal "Emergency Medical Care"
- Vol. 11 (4) , 561-572
Open AccessNeuroprotective Effects of Inhaled Xenon for Sedation Compared With Propofol Intravenous Sedation in Severe Ischemic Stroke
ABSTRACTS Ischemic stroke occupies a leading position among the causes of mortality and disability. Long-lasting motor and cognitive impairments, a decrease in the level of consciousness over time aggravate the course of the disease, leading to immobilization syndrome and comorbidity load, which contributes to the development of life-threatening conditions in this category of patients. In this regard, the search for new neuroprotective strategies used at an early stage and capable of minimizing the severe consequences of stroke for the patient in particular and society as a whole seems extremely relevant. The paper presents the effect of inhaled xenon for sedation in patients with severe ischemic stroke on the level of consciousness and severity of neurological disorders, and also shows its effect on S100B protein, a marker for blood brain barrier damage.AIM OF STUDY To evaluate the effect of inhaled xenon for sedation in comparison with propofol intravenous sedation on the dynamics of the level of consciousness, the severity of neurological dysfunction and changes in the concentration of astroglial-derived S100B protein in severe ischemic stroke.MATERIAL AND METHODS The research was conducted on two groups of patients comparable in age, gender, comorbid background, as well as the severity of the underlying disease. In both groups, the condition of patients required the start of mechanical ventilation immediately after admission to the intensive care unit. Group I (control, n=12). After intubation and the start of ventilation, patients were sedated with propofol at a dose of 1-2 mg/ kg / hour for 24–72 hours. Group II (xenon, n=12). After intubation and the start of ventilation, patients underwent xenon inhalation at a concentration of 40 vol. % for the first 6 hours. If it was necessary to continue sedation after the end of xenon inhalation, propofol was used in doses similar to Group I. Neurological status was assessed on days 1, 3 and 8 using the Glasgow Coma Scale (GCS), the Full Outline of UnResponsivness (FOUR) score and the National Institutes of Health Stroke Scale (NIHSS). The critical analysis of the value of S100B as a marker of brain damage was carried out before the start of sedation, on the 3rd and 8th days.RESULTS Xenon inhalation (40 vol. %) in comparison with propofol intravenous sedation significantly increases the level of consciousness in patients with severe ischemic stroke (p=0,026), reduces neurological disorders assessed using NIHSS (p=0,007) on day 7, and also reduces serum S100B levels on day 3 (pCONCLUSION Our open randomized clinical trial of xenon inhalation versus propofol intravenous sedation revealed the neuroprotective properties of xenon anesthesia in patients with severe ischemic stroke. Based on the obtained clinical and laboratory data, it can be concluded about the effective implementation of the neuroprotective effects of xenon in the administration scheme used in the research.